EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating the Role of High‐Dimensional Proxy Data in Confounding Adjustment in Multiple Sclerosis Research: A Case Study

Mohammad Ehsanul Karim iD, Md Belal Hossain iD, Huah Shin Ng, Feng Zhu, Hanna A Frank, Helen Tremlett iD

Pharmacoepidemiology and Drug Safety · 2025

DOI: 10.1002/pds.70112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Mohammad Ehsanul Karim und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Multiple Sclerosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Multiple Sclerosis Society of Canada, CIHR, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Given the historical use of limited confounders in multiple sclerosis (MS) studies utilizing administrative health data, this brief report evaluates the impact of incorporating high‐dimensional proxy information on confounder adjustment in MS research. We have implemented high‐dimensional propensity score (hdPS) and high‐dimensional disease risk score (hdDRS) methods to assess changes in effect estimates for the association between disease‐modifying drugs (DMDs) and all‐cause mortality in an MS cohort from British Columbia (BC), Canada.

Methods

We conducted a population‐based retrospective study using linked administrative databases from BC, including health insurance registries, demographics, physician visits, hospitalizations, prescriptions, and vital statistics. The cohort comprised 19 360 individuals with MS, followed from January 1, 1996, to December 31, 2017. DMD exposure was defined as at least 180 days of use for beta‐interferon or glatiramer acetate, or at least 90 days for other DMDs. The outcome was time to all‐cause mortality. We compared Cox proportional hazards models adjusting for investigator‐specified covariates with those incorporating additional empirical covariates using hdPS and hdDRS methods.

Results

In the unadjusted analysis, DMD exposure was associated with a 69% lower risk of mortality (HR 0.31; 95% CI: 0.27–0.36). Adjusting for investigator‐specified covariates, the adjusted hazard ratio (aHR) was 0.76 (95% CI: 0.65–0.89). HdPS analyses showed a 20%–23% lower mortality risk (aHRs: 0.77 to 0.80), while hdDRS analyses indicated a 19%–21% reduction (aHRs: 0.79 to 0.81).

Conclusions

Incorporating high‐dimensional proxy information resulted in minor variations in effect estimates compared to traditional covariate adjustment. These findings suggest that the impact of residual confounding in the question under consideration may be modest. Further research should explore additional data dimensions and replicate these findings across different datasets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisHumansFemaleMaleRetrospective StudiesBritish ColumbiaAdultMiddle AgedConfounding Factors, EpidemiologicPropensity ScoreDatabases, FactualProportional Hazards ModelsCohort Studies

Stichwörter der Autor:innen

administrative health dataconfounder adjustmentdisease risk scorehigh‐dimensional datamultiple sclerosispropensity scoreresidual confounding

Autor:innen und Institutionen

  • School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
  • Centre for Advancing Health Outcomes, University of British Columbia, Vancouver, British Columbia, Canada.
  • Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, Australia.
  • SA Pharmacy, SA Health, Adelaide, Australia.
  • Division of Neurology, Department of Medicine, The Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Mohammad Ehsanul Karim, Md Belal Hossain, Helen Tremlett

Förderung

  • Multiple Sclerosis Society of Canada
  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Karim, M. E., Hossain, M. B., Ng, H. S., Zhu, F., Frank, H. A., & Tremlett, H. (2025). Evaluating the Role of High‐Dimensional Proxy Data in Confounding Adjustment in Multiple Sclerosis Research: A Case Study. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70112

Vancouver

Karim ME, Hossain MB, Ng HS, Zhu F, Frank HA, Tremlett H. Evaluating the Role of High‐Dimensional Proxy Data in Confounding Adjustment in Multiple Sclerosis Research: A Case Study. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70112

BibTeX
@article{Karim2025,
  author = {Karim, Mohammad Ehsanul and Hossain, Md Belal and Ng, Huah Shin and Zhu, Feng and Frank, Hanna A and Tremlett, Helen},
  title = {Evaluating the Role of High‐Dimensional Proxy Data in Confounding Adjustment in Multiple Sclerosis Research: A Case Study},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2025},
  doi = {10.1002/pds.70112}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche